Songshan Lake innovation supports the development of bio-industry in six major areas.

In recent years, with the rapid development of genomics and its associated technologies in the world, precision medicine, biosynthesis, industrial breeding and other new models to accelerate the evolution and promotion, the new biological economy is expected to lead human production and life into a new world.
as an important node of Guangdong, Hong Kong, Macao and The Great Bay Area and the Guangshen Science and Technology Innovation Corridor, Dongguan connects the two major scientific and technological innovation leading areas, in the development of bio-industry and other high-tech industries have a comparative advantage unmatched elsewhere, has been built in China's fractured neutron source and other national scientific devices, will provide a strong supporting role in the innovation and development of biological and other emerging industries.
in order to further develop the park's biological industry, promote and promote The Songshan Lake High-tech Zone, July 31, Songshan Lake BioIndustry Promotion Conference held in Songshan Lake, Dongguan.
the conference not only comprehensively demonstrated the Guangdong, Hong Kong and Macao Grand Bay Area under the national strategy of Songshan Lake new development blueprint and huge development opportunities, strongly promote a new round of industrial investment in the park, but also on-site signing, unveiling a number of high-quality bio-industry projects and platforms, and the foreign heavyweight launch edinet Songshan Lake bio-industry development support policy, for Songshan Lake to speed up the construction of a modern economic system, promote the economy towards high-quality development pressed the accelerator.
industry leader and invisible champion go hand in hand with the biological industry is a strategic industry to win the future, but also the key development of Songshan Lake high-tech industry, is the park efforts to build an important part of the modern industrial system. Ouyang Nanjiang, deputy secretary of the Party and Industry Committee of the Songshan Lake High-tech Zone in
, said that at present, the development of the biotechnological industry in the park has four distinct characteristics: First, the trend of industrial agglomeration is obvious.
has successfully introduced more than 300 biological projects, such as Dongsun Pharmaceuticals, Sansheng Pharmaceuticals, Sansheng Pharmaceuticals, Universal Pharmaceuticals, Pumen Technology, Modern Dentistry, Boao Biology, covering biomedicine, biomedical engineering, bio-food and other fields, especially in the fields of medical devices, biomedicine and other fields have achieved an initial industrial concentration, has been Initial formation of the pharmaceutical research and development industry chain, pharmaceutical equipment industry chain, traditional Chinese medicine industry chain, in vitro diagnostic industry chain, research and development institutions industry support chain, biotechnology venture capital industry support chain and other biotechnology industry chain, and equipped with the corresponding multi-level multi-subject industrial funds, in the national biological industry has a certain degree of visibility. the second
is the increasing number of leading enterprises.
in the field of medical devices, the Guangdong Food and Drug Administration announced a total of 92 quality credit Class A medical device manufacturers in 2017, of which 13 have settled or will soon be settled in the park.
into the park enterprise, Dongsun is the domestic children's influenza drug sub-sector leader, Sansheng Pharmaceutical in the domestic biopharmaceutical ranking first, the pharmaceutical industry is China's pharmaceutical industry top 100, Fipeng bio is China's well-known in vitro diagnostic reagent raw materials suppliers, Antgaoco is the domestic high-pressure imaging industry leader, modern dentistry as the world's leading denture equipment supplier.
third is the bright spot enterprises gradually emerging.
in the industry to attract leading enterprises at the same time, the park also actively introduce the cultivation of growth-oriented small and medium-sized enterprises, a number of unique in the field of biological industry sub-sector seishaving enterprises are being built and put into operation.
Fipeng Biology, Red Coral Pharmaceuticals and other projects have been put into operation, Dongsun, Pumen Bio, Antgaoco, modern dentistry and other projects are expected to be completed within this year.
, Pumen Science and Technology won the first prize of the National Science and Technology Progress Award, Bo and Regenerative Medicine won the national key research and development program project, Bo Omuhua was approved the national gene detection technology application demonstration center.
fourth is the continuous improvement of the industry support.
Park is equipped with bio-industry carriers with a total construction area of more than 260,000 square meters, such as the Biotechnology Cooperative Education Center and the Industrialization Center, the introduction of a number of biological technology teaching and scientific research institutions, such as The Institute of Zhongshan University in Dongguan, Guangdong Medical University, and the establishment of a public platform for bio-industry, including the provincial medical device testing center, Dongguan Food and Drug Testing Center, etc., and the establishment of a 600 million yuan-scale bio-industry fund. Special support for industrial development, for biological enterprises to provide registration, product declaration, logistics, terminal sales and other one-stop industrial chain services, the establishment of bio-technology associations to promote industrial exchanges, and actively carry out bio-industry investment and financing docking, industrial forums, recruitment, training, exhibition, technology transfer and docking series of activities, the park's bio-industry support is gradually improved, the bio-industry atmosphere is becoming more and more mature.
has introduced a total investment of more than 10 billion yuan to stand at a new starting point, the biological industry has been included in Dongguan to build a strategic emerging industry "four beams and eight pillars" an important pole.
the "Dongguan Key Emerging Industries Development Plan (2018-2025)" (hereinafter referred to as the "Plan") clearly put forward that by 2025, the life sciences and biotechnology industry output value should reach 100 billion yuan.
" conference is not only a combing demonstration of the park's investment in biotechnology industry, but also the mobilization and determination of the park to promote the development of the bio-industry.
" Ouyang Nanjiang said, "Together with the eight projects signed today, the park's new introduction of bio-industry projects and projects under construction total investment of more than 10 billion yuan."
", the eight contracted projects include the development and pilot platform projects of improved new drugs invested by Guangdong Zhongsheng Pharmaceutical Co., Ltd., the production base of dietary nutrition supplements invested by Shanghai Aisint Biotech Co., Ltd., the production base of peptide raw materials and peptide preparations invested by Shenzhen Vicky Pharmaceutical Research and Development Co., Ltd., and the noord injection pen product production projects invested by Yulong Technology Co., Ltd.
Ouyang Nanjiang said that Songshan Lake, as an important node in building a wide-depth scientific and technological innovation corridor, will take the initiative to undertake the overflowof ingenuity of industrial resources, build new industries, and build a new highland for global innovation-driven development.
the project signed on-site, with high technical content, broad market prospects, good economic benefits and so on, for the park's bio-industry innovation and development into fresh blood.
six areas of innovation to support the development of biological industry is particularly noteworthy, in this industry promotion conference, Songshan Lake announced the "Dongguan Songshan Lake to promote the development of biological industry special funds management measures" (hereinafter referred to as "Management Measures").
this issueof policy covers the biotechnology project research and development, production, market, platform, finance and other key links in the industrialization process, covering a wide range, support, heavy process supervision, operability, is in recent years, Matsuyama Lake issued the "gold content" one of the highest policies.
next, Matsuyama Lake will focus on supporting and rewarding six major aspects of the biological industry, including giving incentives to enterprises in the process of new drug research and development, medical device research and development, giving incentives to new drugs, medical device products, health food and other product certificates, to obtain domestic and international relevant certification and qualifications, to the establishment of research and development centers or service platforms for enterprises, to give incentives to high-level settlement, and to give priority support to major projects.
, in order to encourage the development of new drugs and achieve industrialization in Songshan Lake, the Management Measures give incentives or subsidies according to the results of all stages of the new drug development process: including: the acquisition of chemical drugs in the country 1, Chinese medicine (natural drugs) national category 1, biological products (mainly for therapeutic use The project approved for clinical trials of new drug products, 1-3 categories and preventive biological products, was granted a one-time reward of 1.2 million yuan, 1.6 million yuan and 2 million yuan, respectively;
, Matsuyama Lake will also subsidize the cost of clinical research according to the progress of new drug development, and will be subsidized in phases according to Phase i, II and III of clinical trials.
, if the treatment of biological products 1 -3 categories and preventive biological products 1-2) new drug projects, complete the clinical trial III, and obtain the drug registration declaration acceptance number, to the declaration of enterprises up to 10 million yuan of subsidies.
to obtain chemicals national category 1, Chinese medicine (natural medicine) national class 1, biological products (including: therapeutic biological products 1 - 3 categories of biological products and preventive biological products 1 -2) new drug product registration certificate, and then a one-time give 2 million yuan, 3 million yuan, 5 million yuan of financial incentives;
by the state identified and within the validity period of Dongguan City outside the overall migration of high-tech enterprises or will be set up in Songshan Lake, a one-time award of 400,000 yuan settled;
a local investment in the hardware and software environment is good or bad, the early has settled in the park and put into operation of enterprises have a more comprehensive experience and interpretation.
Feipeng Biological in Songshan Lake capital expansion project has been officially started, the company's vice president Liu Lili said, Feipeng Bio is the first batch of Songshan Lake Project investment and construction of direct landing reform pilot project, so the first phase of the project from design to complete acceptance and put into production, only took less than two years, Songshan Lake government departments to give very big support to enterprise development. After the
Songshan Lake Bioindustry Promotion Conference, the unveiling ceremony was held at the National Gene Detection Technology Application Demonstration Center of BooMuhua Gene Company. Xu Junquan, chief executive officer of Boao Jingdian,
which is responsible for the construction and operation of the center, said that after the opening of the demonstration center, gene detection technology based on high-throughput sequencing platform and gene chip platform will be carried out in the field of prevention and control of major diseases such as birth defects, genetic diseases, tumors, cardiovascular diseases, infectious diseases, and further improve the industry's scientific and technological innovation capabilities, and help Songshan Lake bio-industry to move up the high-end value chain.
.